TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SYNTHON PHARMS

NeurologyCardiovascularMetabolic
Generics

SYNTHON PHARMS is a generic drug manufacturer focused on Neurology, Cardiovascular, Metabolic. Key products include ZOLPIDEM TARTRATE.

2001
Since
9
Drugs
-
Trials
102
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
GLATIRAMER ACETATE 2026-02-11
GLATIRAMER ACETATE 2026-02-11
AMLODIPINE BESYLATE 2026-01-26
Manufacturing (CMC)
AMLODIPINE BESYLATE 2026-01-22
GLATIRAMER ACETATE 2025-12-31
RISPERIDONE 2025-11-04
Labeling
LETROZOLE 2025-10-24
Labeling
ANASTROZOLE 2025-10-24
Labeling
ANASTROZOLE 2025-10-24
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 33%
1 drugs
Cardiovascular 33%
1 drugs
Metabolic 33%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Novo Nordisk big-pharma
Metabolic, Cardiovascular, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Metabolic
AZURITY specialty
Cardiovascular, Neurology, Metabolic
Merck big-pharma
Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Cardiovascular, Metabolic